Article Text

Concise report
Expansion of myelin autoreactive CD8+ T lymphocytes in patients with neuropsychiatric systemic lupus erythematosus
  1. Cécile Contin-Bordes1,2,
  2. Estibaliz Lazaro2,3,
  3. Christophe Richez2,4,
  4. Clément Jacquemin2,
  5. Olivier Caubet3,
  6. Isabelle Douchet2,
  7. Jean-François Viallard3,
  8. Jean-François Moreau1,2,
  9. Jean-Luc Pellegrin3,
  10. Patrick Blanco1,2,3
  1. 1Laboratoire d'Immunologie, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France
  2. 2CNRS-UMR5164 Université Victor Segalen, Bordeaux, France
  3. 3Service de Médecine Interne, CHU de Bordeaux, Pessac, France
  4. 4Service de Rhumatologie, CHU de Bordeaux, Bordeaux, France
  1. Correspondence to Dr Patrick Blanco, Laboratoire d'Immunologie, Place Amélie Raba-Léon, 33076 Bordeaux Cedex, France;{at}


Objectives Delineation of mechanisms underlying neuropsychiatric systemic lupus erythematosus (NPSLE) and determination of biological markers could guide treatment choice. A study was undertaken to analyse the potential role of activated CD8+ T cells in NPSLE as previously reported in SLE nephritis.

Methods Flow cytometric immunophenotyping of blood lymphocytes was performed in 30 patients with NPSLE and 36 healthy individuals. The antigenic specificity of CD8+ T cells was studied using HLA-A0201 tetramers loaded with several myelin-derived peptides. The intracellular level of interferon γ (IFNγ) produced by activated CD8+ T cells was determined by flow cytometry.

Results A large increase in circulating activated CD8+ T lymphocytes expressing surface HLA-DR was found in patients with NPSLE without antiphospholipid syndrome (APS) (n=18) compared with patients with APS (n=12) or healthy controls (n=36). IFNγ-secreting myelin-specific CD8+ T cells were detected exclusively in the blood of patients with NPSLE without APS but with white matter lesions.

Conclusions These data strongly support the existence of a new immune effector mechanism responsible for CNS involvement in patients with NPSLE and suggest that analysing HLA-DR expression combined with myelin-specific tetramer staining on CD8+ T lymphocytes may be a valuable additional tool for the monitoring of these patients.

Statistics from


  • CCB and EL contributed equally

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.